241 related articles for article (PubMed ID: 20921456)
21. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.
Pollack IF; Jakacki RI; Blaney SM; Hancock ML; Kieran MW; Phillips P; Kun LE; Friedman H; Packer R; Banerjee A; Geyer JR; Goldman S; Poussaint TY; Krasin MJ; Wang Y; Hayes M; Murgo A; Weiner S; Boyett JM
Neuro Oncol; 2007 Apr; 9(2):145-60. PubMed ID: 17293590
[TBL] [Abstract][Full Text] [Related]
22. SAFETY AND TOLERABILITY OF VANDETANIB IN JAPANESE PATIENTS WITH MEDULLARY THYROID CANCER: A PHASE I/II OPEN-LABEL STUDY.
Uchino K; Komoda M; Tomomatsu J; Okamoto T; Horiuchi K; Tsuji A; Ito Y; Todo T; Rito K; Takahashi S
Endocr Pract; 2017 Feb; 23(2):149-156. PubMed ID: 27819766
[TBL] [Abstract][Full Text] [Related]
23. A phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumors.
Tamura T; Minami H; Yamada Y; Yamamoto N; Shimoyama T; Murakami H; Horiike A; Fujisaka Y; Shinkai T; Tahara M; Kawada K; Ebi H; Sasaki Y; Jiang H; Saijo N
J Thorac Oncol; 2006 Nov; 1(9):1002-9. PubMed ID: 17409986
[TBL] [Abstract][Full Text] [Related]
24. Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.
Wells SA; Gosnell JE; Gagel RF; Moley J; Pfister D; Sosa JA; Skinner M; Krebs A; Vasselli J; Schlumberger M
J Clin Oncol; 2010 Feb; 28(5):767-72. PubMed ID: 20065189
[TBL] [Abstract][Full Text] [Related]
25. Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma.
Tinkle CL; Campbell K; Han Y; Li Y; Bianski B; Broniscer A; Khan RB; Merchant TE
J Neurooncol; 2020 Mar; 147(1):195-203. PubMed ID: 32016716
[TBL] [Abstract][Full Text] [Related]
26. Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas.
Haas-Kogan DA; Banerjee A; Poussaint TY; Kocak M; Prados MD; Geyer JR; Fouladi M; Broniscer A; Minturn JE; Pollack IF; Packer RJ; Boyett JM; Kun LE
Neuro Oncol; 2011 Mar; 13(3):298-306. PubMed ID: 21339191
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors.
Holden SN; Eckhardt SG; Basser R; de Boer R; Rischin D; Green M; Rosenthal MA; Wheeler C; Barge A; Hurwitz HI
Ann Oncol; 2005 Aug; 16(8):1391-7. PubMed ID: 15905307
[TBL] [Abstract][Full Text] [Related]
28. Measurable Supratentorial White Matter Volume Changes in Patients with Diffuse Intrinsic Pontine Glioma Treated with an Anti-Vascular Endothelial Growth Factor Agent, Steroids, and Radiation.
Svolos P; Reddick WE; Edwards A; Sykes A; Li Y; Glass JO; Patay Z
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1235-1241. PubMed ID: 28428205
[TBL] [Abstract][Full Text] [Related]
29. A Phase II Trial of Vandetanib in Children and Adults with Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor.
Glod J; Arnaldez FI; Wiener L; Spencer M; Killian JK; Meltzer P; Dombi E; Derse-Anthony C; Derdak J; Srinivasan R; Linehan WM; Miettinen M; Steinberg SM; Helman L; Widemann BC
Clin Cancer Res; 2019 Nov; 25(21):6302-6308. PubMed ID: 31439578
[TBL] [Abstract][Full Text] [Related]
30. Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study.
Chheda MG; Wen PY; Hochberg FH; Chi AS; Drappatz J; Eichler AF; Yang D; Beroukhim R; Norden AD; Gerstner ER; Betensky RA; Batchelor TT
J Neurooncol; 2015 Feb; 121(3):627-34. PubMed ID: 25503302
[TBL] [Abstract][Full Text] [Related]
31. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
[TBL] [Abstract][Full Text] [Related]
32. Randomized phase II study of vandetanib alone or with paclitaxel and carboplatin as first-line treatment for advanced non-small-cell lung cancer.
Heymach JV; Paz-Ares L; De Braud F; Sebastian M; Stewart DJ; Eberhardt WE; Ranade AA; Cohen G; Trigo JM; Sandler AB; Bonomi PD; Herbst RS; Krebs AD; Vasselli J; Johnson BE
J Clin Oncol; 2008 Nov; 26(33):5407-15. PubMed ID: 18936474
[TBL] [Abstract][Full Text] [Related]
33. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
Korones DN; Fisher PG; Kretschmar C; Zhou T; Chen Z; Kepner J; Freeman C
Pediatr Blood Cancer; 2008 Feb; 50(2):227-30. PubMed ID: 17278121
[TBL] [Abstract][Full Text] [Related]
34. The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma.
Michalski A; Bouffet E; Taylor RE; Hargrave D; Walker D; Picton S; Robinson K; Pizer B; Bujkiewicz S
J Neurooncol; 2010 Oct; 100(1):81-8. PubMed ID: 20238235
[TBL] [Abstract][Full Text] [Related]
35. Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution.
Chiang KL; Chang KP; Lee YY; Huang PI; Hsu TR; Chen YW; Chang FC; Wong TT
Childs Nerv Syst; 2010 Aug; 26(8):1035-41. PubMed ID: 20217098
[TBL] [Abstract][Full Text] [Related]
36. Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer.
Michael M; Gibbs P; Smith R; Godwood A; Oliver S; Tebbutt N
Invest New Drugs; 2009 Jun; 27(3):253-61. PubMed ID: 19002384
[TBL] [Abstract][Full Text] [Related]
37. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
Cancer; 2005 Nov; 104(9):1968-74. PubMed ID: 16177987
[TBL] [Abstract][Full Text] [Related]
38. A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas.
Hipp SJ; Goldman S; Kaushal A; Krauze A; Citrin D; Glod J; Walker K; Shih JH; Sethumadhavan H; O'Neill K; Garvin JH; Glade-Bender J; Karajannis MA; Atlas MP; Odabas A; Rodgers LT; Peer CJ; Savage J; Camphausen KA; Packer RJ; Figg WD; Warren KE
J Neurooncol; 2020 Sep; 149(3):437-445. PubMed ID: 33040274
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer.
Kiura K; Nakagawa K; Shinkai T; Eguchi K; Ohe Y; Yamamoto N; Tsuboi M; Yokota S; Seto T; Jiang H; Nishio K; Saijo N; Fukuoka M
J Thorac Oncol; 2008 Apr; 3(4):386-93. PubMed ID: 18379357
[TBL] [Abstract][Full Text] [Related]
40. Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group.
Broniscer A; Leite CC; Lanchote VL; Machado TM; Cristófani LM
J Clin Oncol; 2000 Mar; 18(6):1246-53. PubMed ID: 10715294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
